In this Q&A, Krishna Cheriath, VP and head of clinical research digital data and AI at Thermo Fisher Scientific, examines how ...
In today's ACT Brief, we examine why expanding governance layers slow digital modernization initiatives, how AI will augment ...
Angela Zubel, chief development officer at Debiopharm, framed 2026 as an implementation year—the moment when AI tools move from pilot programs into meaningful daily operations across drug development.
In today's ACT Brief, we examine how real-world data is being applied across oncology, ophthalmology, and other therapeutic ...
Pharma modernization initiatives stall not from lack of ambition but from expanding governance layers that distance ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
Kole identified workflow guidance as the most underaddressed gap in current eClinical ecosystems, arguing that technology has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results